Editorial: Cardiovascular remodeling

Frontiers in Pharmacology

Pharmacology

Ming Lei¹  Yi Zhang²  Yan Yang³  Gui-Rong Li⁴ 

[1] Department of Pharmacology, University of Oxford, Oxford, United Kingdom;Department of Physiology, Hebei Medical University, Shijiazhuang, China;Key Laboratory of Medical Electrophysiology of Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China;Nanjing Amazigh Pharma Ltd., Nanjing, China;

关键词: cardiovascular diseases (CVDs);    cardiovascular remodeling;    genetic studies;    dysfunction;    drug therapy;   

DOI  :  10.3389/fphar.2023.1252598

 received in 2023-07-04, accepted in 2023-07-18,  发布年份 2023

来源: Frontiers

【 摘 要 】

GRAPHICAL ABSTRACT

【 授权许可】

Unknown   
Copyright © 2023 Yang, Zhang, Li and Lei.